FdaApplication
NDA 208325
Identifiers
- fda_app_no: NDA208325
Properties
| Property | Value |
|---|---|
| applicant_name | KAI PHARMACEUTICALS INC A WHOLLY OWNED SUBSIDIARY OF AMGEN INC |
| application_type | NDA |
| approval_date | 2017-02-07 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PARSABIV | ETELCALCETIDE | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION;INTRAVENOUS |
| PARSABIV | ETELCALCETIDE | 10MG/2ML (5MG/ML) | SOLUTION;INTRAVENOUS |
| PARSABIV | ETELCALCETIDE | 5MG/ML (5MG/ML) | SOLUTION;INTRAVENOUS |
3 products